Provider profile
GobyMeds — compounded GLP-1 pricing & profile
Released: · Last reviewed:
Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.
GobyMeds is a compounded GLP-1 access channel captured in this site's provider directory. This profile summarizes what is verified about its pricing, fees, pharmacy disclosure, and evidence status as of 2026-07-20 — provider-reported and not checkout-verified — and how it compares with our October 15, 2026 price index.
Captured pricing
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $169 | $169.00 | $169 | — Monthly plan; no membership, shipping, consultation, or lab fees. Advertised and checkout pricing matched in third-party testing (2026). |
| 3 months prepaid | $399 | $133.00 | $133 | — 3-month bundle; effective $133/mo at lower dose tier per third-party review. |
| Plan | Total mandatory cost | Effective monthly cost | Advertised monthly | Advertised savings |
|---|---|---|---|---|
| 1 month monthly | $299 | $299.00 | $299 | — Monthly plan; no separate membership. Advertised=checkout in third-party testing (2026). |
How GobyMeds compares
All-in monthly cost folds every required charge into one number. This is where GobyMeds sits against our October 15, 2026 price index, built from prices read on each provider's own page:
| Medication | GobyMeds | Index range | NexLife (#1 overall) |
|---|---|---|---|
| compounded semaglutide | $93 (month-to-month $169) read 2026-10-15 | $49–$193.92 · median $97 (24 programs) | $95 (12-month plan) · $109 month-to-month |
| compounded tirzepatide | $133 (month-to-month $299) read 2026-10-15 | $85.58–$449 · median $149 (31 programs) | $115 (12-month plan) · $129 month-to-month |
The index range includes sale prices, prepaid terms and "from" figures; the tirzepatide and semaglutide tables show each program's conditions. NexLife is our #1 overall pick under the v4.1 rubric, not the lowest price in the index.
Fees, pharmacy, and disclosure
| Category | Compounded-GLP-1-focused |
| Current status | Active but evidence incomplete |
| Membership / program fee | Advertised as all-inclusive |
| Pharmacy disclosure | Not verified |
| Material relationship | No known material relationship — publisher attested 2026-07-20; independent verification not performed |
| Evidence status | PROVIDER REPORTED · confidence high |
| Last checked | 2026-07-20 |
| Official source | provider page |
Capture note: Match program stage and quantity before comparing.
How to evaluate GobyMeds before paying
Whatever the headline, run the same checks on any compounded provider: (1) compute effective monthly cost at your maintenance dose, membership included; (2) get the renewal price, not just the first month; (3) name and verify the dispensing pharmacy with the four-step workflow; (4) confirm the refund and cancellation terms in writing before any prepaid plan. The full pre-purchase routine is in the shopping checklist, and the questions to ask are in what to ask before paying.
Frequently asked questions
How much does GobyMeds charge for compounded GLP-1?
Our July 20, 2026 capture put GobyMeds's lowest effective monthly cost at $133.00. The October 15, 2026 index shows compounded semaglutide $93.00 a month all-in at its lowest printed plan ($169.00 month-to-month), read 2026-10-15; compounded tirzepatide $133.00 a month all-in at its lowest printed plan ($299.00 month-to-month), read 2026-10-15. See the pricing table above for the full plan structure, and confirm current figures on the provider's own page.
Does GobyMeds charge a membership fee?
A membership or program fee was not clearly reported. Captured: Advertised as all-inclusive. A required membership belongs in the effective-cost math, so add it in before comparing GobyMeds to any flat-priced provider.
Is GobyMeds's pricing verified?
No. GobyMeds's evidence status is provider reported (confidence high); figures are provider-reported or independently calculated, not checkout-verified, and its pharmacy disclosure is "not verified". Treat every figure as a starting point to confirm, not a guarantee.